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1. Introduction 
Bone resorption is stimulated by parathyroid 
hormone (PTH) and 1,25dihydroxyvitamin D3 
(1 ,25(OH)*DB) [ 1,2 1. Cyclic adenosine 3’S’-mono- 
phosphate (CAMP) is implicated in this action ot 
PTH [3,4], although not in that of 1,25(OH)zDs. 
Although the osteoclast is the major bone resorbing 
cell, studies with isolated bone cells point increasingly 
to the fact that the effects of PTH on CAMP produc- 
tion in bone result from actions upon osteoblasts 
rather than osteoclasts [S-9]. A transplantable osteo- 
genic sarcoma in the rat, which has been shown to 
consist of cells with the features of osteoblasts 
[lo-131 has retained for several years a PTH-respon- 
sive adenylate cyclase and high cellular level of 
alkaline phosphatase [11,14,15]. Here we report 
the development of clones of this osteogenic sarcoma, 
which have an active adenylate cyclase response to 
PTH and high alkaline phosphatase activity, and are 
enriched in a cytosol receptor for the bone resorbing 
steroid hormone, 1,25 <OH)*D3. 
2. Materials and methods 
The osteogenic sarcoma was propagated and 
cultured as in [9,10]. Single cell suspensions were 
prepared from adherent monolayer primary cultures 
by harvesting with pronase (0.01% Calbiochem) 
in phosphate-buffered saline and 0.02% EDTA 
for 10 min at room temperature. After washing, 
the cells were plated at 200 viable cells/35 mm dish 
in a double layer nutrient agar system [161. The 
dishes were incubated for 14 days at 37°C in sealed 
ElsevierfNorth-Holland Biomedical Press 
plastic boxes gassed with 7% oxygen, 10% COz, 83% 
nitrogen, this low oxygen tension having been found 
to promote better colony growth. The cloning 
efficiency in this system ranged from 4-7.5%. 
Individual clones were picked up using sterile micro- 
pipettes and were reseeded into alpha modification 
of Eagle’s medium with 20% fetal calf serum (Flow 
Labs.) and chlortetracycline (50 pgirnl) in 25 cm2 
plastic culture flasks (Costar). When adherence and 
spreading occurred, the cells were harvested and 
reseeded into 25 cm2 flasks. Cultures were refed 
weekly until the cells reached 90% confluency, 
when they were subcultured. 
Alkaline and acid phosphatase (EC 3.1.3.1 and EC 
3.1.3.2, respectively) activities in lysed cells [8] 
and adenylate cyclase (EC 4.6.1 .l) activity in homog- 
enates of cultured cells [8,14] were assayed as 
described. Sources of parathyroid hormone, PGE2, 
calcitonin and vitamin D metabolites have been 
reported [8,17]. 
For studies of 1 ,25-(OH)2D3 binding, cells at or 
near confluence were grown for at least 24 h in Eagle’s 
medium containing 10m6 M cortisol and fetal calf 
serum (5%) which had been treated with dextran- 
coated charcoal to remove steroid hormones [17,18]. 
Cytosol preparations were prepared freshly as in 
[17] for cultured human breast cancer cells except 
that 0.4 M KC1 was included in the extraction buffer. 
Sucrose gradient analysis was carried out on 4-20% 
sucrose gradients [ 171. 
3. Results 
From >20 clones grown originally in agar, 4 
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(designated UMR 104,105, 106, 108) were examined 
in detail. The enzyme activities in uncloned osteo- 
genic sarcoma cell cultures up to the third passage 
were 26.45 It 1.59 (alkaline phosphatase, 35 expt) and 
3.04 f 0.27 (acid phosphatase, 10 expt) pmol . h” . mg 
protein- 1 in experiments carried out at regular inter- 
vals over 2 years. The results in table 1 indicate that 
the clonal lines are enriched in alkaline phosphatase 
activity relative to the parent cultured cells. These 
are maintained uring propagation i  culture, as 
also are the relative activities in the different clones 
(data not shown). All clonal lines retain PTH-respon- 
sive adenylate cyclase, and in clone UMR 106 this is 
enhanced, with a 12.fold increase in activity in 
response to a ma~m~ly a~tivat~g concentration 
of hormone. 
In preliminary experiments with uncloned cells 
it was possible to demonstrate specific binding of 
3H-labelled 1,25-(OH)2D3 in cytosol preparations. 
However the large amounts of protein required to 
obtain sufficient bound radioacti~ty resulted in 
increased non-specific binding. Under these circum- 
stances it is possible that erroneous estimates of 
receptor concentration and affmity are obtained 
[ 19 1. In several clones there was substantial enrich- 
ment in the cytosol receptor for 1 ,Z-(OH)sDs, 
which allowed competition curves and Scatchard 
analysis to be carried out using appropriately small 
amounts of cytosol protein. The cloned osteogenic 
sarcoma cell lines contained specific receptors for 
1 ,25(OH)2Ds (fig.1). Similar data was obtained with 
all 4 clones. Scatchard analysis of the 4 clones indi- 
cated a single class of high affinity receptors (fig.2) 
with dissociation constants and receptor concentra- 
tions (table 1) similar to those found with cultured 
human breast cancer cells [ 171. Ultracentrifugal nal- 
ysis (flg.3) revealed that the cytosol receptor was a 
3.5 S ma~omole~~e, asfound for the receptor 
in human breast cancer 1171 and rachitic chicken 
intestine [20]. 
4. Discussion 
The malignant tumour from which these 4 clones 
were derived has been characterized extensively as 
osteoblast in nature [8,10-131. Furthermore it is 
clear from the present data that the cloned cells 
are targets for the bone resorbing hormones, PTH am 
1 ,25(OH)%D3. The only available data on their action 
n 
1,000- 
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Fig.1. Competitive binding analysis of ’ H&belled 
1,25-(OH),D, binding in cytosol from UMR 108. Competing 
vitamin D metabolites; 1,25_fOH),D, (a), 25_OH-D, (0) and 
24,25-(OH),D, (=). Values are mean i SEM of triplicate 
determinations. Testosterone, dihydrotestosterone, oestra- 
diol, progesterone, cortisol, dexamethasone and aldosterone 
at ~10~~ M did not compete with “H-label&I 1,25_(OH),D, 
binding. 
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Fig.2. Scatchard analysis of 1,25_(OH),D, receptor bin&g 
in cloned cell lines. UMR 104 co), UMR 105 (a) UMR 
106 (e) and UMF 108 (m). 
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Fig.3. Sucrose density gradient analysis of 3 H-IabeIled 
1,25-(OH),D, binding in two of the cloned cell lines. 3 H-label- 
led 1,25-(OH),D, binding in the presence (0) and absence (*) 
of 160-fold molar excess of unlabeIIed 1,25-(0H),D, are 
shown. Arrows indicate sedimentation positions of bovine 
serum albumin (1) and ov~bum~ (2). 
in normal osteoblast-rich populations indicates that 
both hormones decrease alkaline phosphatase, citrate 
decarboxylation and collagen synthesis [21]. How- 
ever none of these effects can be definitely related to 
the stimulation of bone resorption by the hormones. 
It will be of considerable interest o define the nature 
of the actions of these hormones on the cloned 
osteoblast-like c ll populations, and to determine 
whether this relates in any way to physiological bone 
resorption. 
A receptor for 1 ,25-(OH)zD3 has been reported 
in cytosol prepared from bone [22]. In view of the 
stimulator action of 1,25-(OH),Da on osteoclastic 
bone resorption, the osteoclast might be expected 
to have a 1,25(OH)1D3 receptor. This has yet to 
be demonstrated, but these results establish that 
osteoblast-like c lls possess such a receptor. Further- 
more although CAMP is suggested as an intermediate 
in PTH stimulation of bone resorption, only osteo- 
blastic bone cells have been demonstrated to respond 
to PTH with a CAMP increase and activation of 
cAMPdependent protein kinase [9]. There is no 
evidence that osteoclast CAMP is changed by PTH. 
These data provide support for the hypothesis that 
the osteoblast might act as a transducer of bone 
resorbing stimuli to the osteoclast [8 J, besides pro- 
viding a convenient target cell in which to study 
molecular mechanisms of 1 ,25(OH)2D3 action. 
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